Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine Extension in Osteoarthritis Knee Pain
NCT02335346Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2015
- Primary completion
- Mar 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in osteoarthritis (OA), sponsored by Eli Lilly and Company. Started Jan 2015; status: completed.
02
Drugs
duloxetine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02335346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335346.